Patent · US Active

RNA interference suppression of neurodegenerative diseases and methods of use thereof

US8481710B2 · kind B2 · utility

30Cited by
33References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 9, 2010
Grant dateJul 9, 2013
Priority date
Expiry dateDec 9, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to small interfering RNA molecules (siRNA) targeted against nucleic acid sequence that encodes huntingtin or ataxin-1, and methods of using these siRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.